SRZN

Surrozen, Inc./DE SRZN

NasdaqSmall CapHealthcare

13F Pro quality score

Rank #2,770 of 2,925

Why it scores 18Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed. Next update: ~Nov 14, 2026.

Revenue

$5.00M

Quarter to Jun 30

Net income

$50.18M

Quarter to Jun 30

Free cash flow

$-7.43M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$319.41M total
Column Group LLC
$49.74M0.0%
TCG Crossover Management, LLC
$38.23M0.0%
Boxer Capital Management, LLC
$26.96M+40.7%
MILLENNIUM MANAGEMENT LLC
$17.73M-6.6%
Point72 Asset Management, L.P.
$17.24MNew
VR Adviser, LLC
$16.42M0.0%
StemPoint Capital LP
$13.79M+207.6%
PERCEPTIVE ADVISORS LLC
$13.08M+69.3%
Spruce Street Capital LP
$11.21M0.0%
BlackRock, Inc.
$10.25M+1317.8%
VANGUARD CAPITAL MANAGEMENT LLC
$10.19M+132.2%
BRAIDWELL LP
$10.14M-1.3%
Kalehua Capital Management LLC
$10.00M0.0%
Vestal Point Capital, LP
$7.91M-10.0%
5AM Venture Management, LLC
$7.04M-30.0%
Vivo Capital, LLC
$6.75M0.0%
BALYASNY ASSET MANAGEMENT L.P.
$5.32M+0.6%
GEODE CAPITAL MANAGEMENT, LLC
$5.23M+206.2%
Stonepine Capital Management, LLC
$4.71M+106.0%
ACUTA CAPITAL PARTNERS, LLC
$4.50M+0.3%
REGENTS OF THE UNIVERSITY OF CALIFORNIA
$3.46M0.0%
STATE STREET CORP
$3.45M+380.0%
GOLDMAN SACHS GROUP INC
$2.95M+339.2%
ADAGE CAPITAL PARTNERS GP, L.L.C.
$2.30M0.0%
Euclidean Capital LLC
$2.28M0.0%
See all 78 institutional holders →
Reading the latest SEC filing…

Key Metrics

Revenue

Q2 2026
EDGAR

Net Income

Q2 2026
EDGAR

EPS (Diluted)

Q2 2026
EDGAR

Free Cash Flow

Q2 2026
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/SRZN

Earnings Per Share

13fpro.ai/company/SRZN

Loading ratio trend…

SRZN key financials by period

Reported revenue, net income and operating margin by fiscal year, from Surrozen, Inc./DE's annual filings on SEC EDGAR.

Surrozen, Inc./DE reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2025$3.5M$-242.0M—
FY 2024$10.7M$-63.6M—
FY 2022$12.5M$-36.0M—
Source: SRZN filings on SEC EDGAR →

SRZN insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About Surrozen, Inc./DE (SRZN): stock profile, AI score and financials

Surrozen, Inc./DE (SRZN) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores SRZN at 18.2/100 on a composite quality score built from its SEC filings, placing it at rank #2,770 of 2,925 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), Surrozen, Inc./DE reports quarterly revenue of $5.0M, net income of $50.2M, free cash flow of $-7.4M. Top institutional holders of SRZN by reported 13-F value include Column Group, TCG Crossover Management, Boxer Capital Management, based on the most recent SEC filings. SRZN trades on the Nasdaq exchange and files with the SEC under CIK 1824893. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate SRZN daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Surrozen, Inc./DE directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 1824893 →